234 related articles for article (PubMed ID: 31189160)
1. Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.
Schupp T; Behnes M; Weiss C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Weidner K; Akin M; Mashayekhi K; Borggrefe M; Akin I
Cardiology; 2019; 142(3):129-140. PubMed ID: 31189160
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
[TBL] [Abstract][Full Text] [Related]
3. Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients.
Weidner K; Behnes M; Weiß C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Schupp T; Kim SH; Barth C; Hoppner J; Akin M; Mashayekhi K; Borggrefe M; Akin I
Heart Vessels; 2019 Nov; 34(11):1811-1822. PubMed ID: 31076852
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.
Schupp T; Akin I; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; Mashayekhi K; Weiß C; Nienaber C; Akin M; Borggrefe M; Behnes M
Clin Res Cardiol; 2019 Aug; 108(8):878-891. PubMed ID: 30756152
[TBL] [Abstract][Full Text] [Related]
5. Digitalis therapy in patients with ventricular tachyarrhythmias.
Schupp T; Müller J; von Zworowsky M; Abumayyaleh M; Weidner K; Rusnak J; Mashayekhi K; Bertsch T; Akin I; Behnes M
Scand Cardiovasc J; 2022 Dec; 56(1):198-207. PubMed ID: 35792713
[No Abstract] [Full Text] [Related]
6. No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias.
Schupp T; Akin I; Reiser L; Bollow A; Taton G; Borggrefe M; Reichelt T; Ellguth D; Engelke N; Barre M; Müller J; Weidner K; Kim SH; Akin M; Große Meininghaus D; Behnes M
Pacing Clin Electrophysiol; 2021 Feb; 44(2):213-224. PubMed ID: 33314234
[TBL] [Abstract][Full Text] [Related]
7. Hypokalemia but not Hyperkalemia is Associated with Recurrences of Ventricular Tachyarrhythmias in ICD Recipients.
Schupp T; Behnes M; Zworowsky MV; Kim SH; Weidner K; Rusnak J; Kuche P; Müller J; Barth C; Reiser L; Taton G; Reichelt T; Ellguth D; Engelke N; Bollow A; Kittel M; Bertsch T; Mashayekhi K; Borggrefe M; Akin I
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162892
[TBL] [Abstract][Full Text] [Related]
8. Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter-defibrillator recipients treated with single beta-blocker or combined amiodarone.
Schupp T; Behnes M; Kim SH; Müller J; Weidner K; Reiser L; Huseynov A; Bollow A; Borggrefe M; Taton G; Reichelt T; Ellguth D; Engelke N; Akin M; Große Meininghaus D; Bertsch T; Akin I
Basic Clin Pharmacol Toxicol; 2021 Mar; 128(3):493-502. PubMed ID: 33174309
[TBL] [Abstract][Full Text] [Related]
9. Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients.
Erath JW; Vamos M; Hohnloser SH
Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):168-74. PubMed ID: 27533758
[TBL] [Abstract][Full Text] [Related]
10. Non-ischemic compared to ischemic cardiomyopathy is associated with increasing recurrent ventricular tachyarrhythmias and ICD-related therapies.
Rusnak J; Behnes M; Weiß C; Nienaber C; Reiser L; Schupp T; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Weidner K; Akin M; Mashayekhi K; Borggrefe M; Akin I
J Electrocardiol; 2020; 59():174-180. PubMed ID: 32179288
[TBL] [Abstract][Full Text] [Related]
11. Impact of Left Ventricular Ejection Fraction on Recurrent Ventricular Tachyarrhythmias in Recipients of Implantable Cardioverter Defibrillators.
Rusnak J; Behnes M; Weiß C; Nienaber C; Reiser L; Schupp T; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Weidner K; Barth C; Kim SH; Akin M; Mashayekhi K; Große Meininghaus D; Borggrefe M; Akin I
Cardiology; 2020; 145(6):359-369. PubMed ID: 32289772
[TBL] [Abstract][Full Text] [Related]
12. Safety of Outpatient Milrinone Infusion in End-Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias.
Harhash AA; Cassuto J; Hussein A; Achu E; Zucker MJ; Goldschmidt M; Alpert JS; Baran DA
Am J Med; 2020 Jul; 133(7):857-864. PubMed ID: 31883773
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter-Defibrillator Therapies.
Schupp T; Behnes M; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Bertsch T; Akin M; Mashayekhi K; Borggrefe M; Akin I
J Cardiovasc Pharmacol; 2019 May; 73(5):272-281. PubMed ID: 30747784
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Atrial Fibrillation in Electrical Storm.
Müller J; Behnes M; Ellguth D; Schupp T; Taton G; Reiser L; Engelke N; Reichelt T; Bollow A; Kim SH; Barth C; Rusnak J; Weidner K; Mashayekhi K; Akin M; Bertsch T; Weiß C; Borggrefe M; Akin I
Cardiology; 2019; 144(1-2):9-17. PubMed ID: 31527375
[TBL] [Abstract][Full Text] [Related]
15. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
16. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of coronary chronic total occlusion on recurrences of ventricular tachyarrhythmias and ICD therapies.
Behnes M; Mashayekhi K; Kuche P; Kim SH; Schupp T; von Zworowsky M; Reiser L; Bollow A; Taton G; Reichelt T; Borggrefe M; Ellguth D; Engelke N; Weidner K; Lindner S; Müller J; Ansari U; Meininghaus DG; Bertsch T; Lang S; Akin I
Clin Res Cardiol; 2021 Feb; 110(2):281-291. PubMed ID: 33150467
[TBL] [Abstract][Full Text] [Related]
18. Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter-defibrillator.
Abbas H; Younis A; Goldenberg I; McNitt S; Aktas MK; Tabaja C; Ojo A
J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1203-1211. PubMed ID: 38606650
[TBL] [Abstract][Full Text] [Related]
19. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure.
Jędrzejczyk-Patej E; Mazurek M; Lazar M; Pruszkowska-Skrzep P; Sokal A; Kowalczyk J; Kowalski O; Kalarus Z; Lenarczyk R
Kardiol Pol; 2023; 81(10):998-1005. PubMed ID: 37936556
[TBL] [Abstract][Full Text] [Related]
20. [2 year follow-up of 321 patients with an implantable cardioverter/defibrillator: comparison of patients with and without atrial fibrillation].
Ryan S; Siemon G; Drögemüller A; Rameken M; Vater M; Senges J; Seidl K
Z Kardiol; 2001 Dec; 90(12):906-15. PubMed ID: 11826832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
